MANAGEMENT RETENTION AGREEMENTManagement Retention Agreement • April 28th, 2011 • Ap Pharma Inc /De/ • Pharmaceutical preparations • California
This Management Retention Agreement (the “Agreement”) is dated as of April 25, 2011, by and between John B. Whelan (“Employee”) and A.P. Pharma, Inc., a Delaware corporation (the “Company”). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.
SECURITY AGREEMENTPatent Security Agreement • April 28th, 2011 • Ap Pharma Inc /De/ • Pharmaceutical preparations • California
This SECURITY AGREEMENT (this “Agreement”), dated as of April 24, 2011 among A.P. PHARMA, INC. and those additional entities that hereafter become parties hereto by executing the form of Supplement attached hereto as Annex 1 (“Grantor”), and TANG CAPITAL PARTNERS, LP, in its capacity as representative of the Purchasers (together with its successors, “Agent”).
SECURITIES PURCHASE AGREEMENT AMONG A.P. PHARMA, INC., TANG CAPITAL PARTNERS, LP, BAKER BROS. INVESTMENTS II, L.P., BAKER BROTHERS LIFE SCIENCES, L.P., AND 14159, L.P. DATED AS OF APRIL 24, 2011Securities Purchase Agreement • April 28th, 2011 • Ap Pharma Inc /De/ • Pharmaceutical preparations • California
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 24, 2011 by and among A.P. Pharma, Inc., a Delaware corporation (the “Company”), Tang Capital Partners, LP, a Delaware limited partnership, Baker Bros. Investments II, L.P., a Delaware limited partnership, Baker Brothers Life Sciences, L.P., a Delaware limited partnership and 14159, L.P., a Delaware limited partnership (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 12 hereof.
SECOND AMENDMENT TO LEASELease • April 28th, 2011 • Ap Pharma Inc /De/ • Pharmaceutical preparations
This Second Amendment to Lease (“Amendment”) is entered into as of April 1, 2011 (the “Effective Date”) by and between METROPOLITAN LIFE INSURANCE COMPANY, a New York corporation (“Landlord”), and AP PHARMA, INC., a Delaware corporation (“Tenant”), with reference to the following facts (“Recitals”):
